Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD (PHTHALO-205)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04331730
Recruitment Status : Completed
First Posted : April 2, 2020
Last Update Posted : October 11, 2021
Information provided by (Responsible Party):
Alkahest, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 19, 2021
Actual Study Completion Date : September 16, 2021